Sixty Degrees Pharmaceuticals And Tufts Medical Center Sign Patent License Agreement To Develop Tafenoquine For Babesiosis Treatment And Prevention; 60 Degrees Gains Exclusive Commercialization Rights With Revenue Sharing And Joint Patent Ownership...
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.